The COVID-19 pandemic in the African continent.

Africa COVID Coronavirus Coverage Epidemiology Essential health services Health Immunity Infectious disease Pandemic Vaccination

Journal

BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723

Informations de publication

Date de publication:
02 05 2022
Historique:
received: 05 04 2022
accepted: 05 04 2022
entrez: 3 5 2022
pubmed: 4 5 2022
medline: 6 5 2022
Statut: epublish

Résumé

In December 2019, a new coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and associated disease, coronavirus disease 2019 (COVID-19), was identified in China. This virus spread quickly and in March, 2020, it was declared a pandemic. Scientists predicted the worst scenario to occur in Africa since it was the least developed of the continents in terms of human development index, lagged behind others in achievement of the United Nations sustainable development goals (SDGs), has inadequate resources for provision of social services, and has many fragile states. In addition, there were relatively few research reporting findings on COVID-19 in Africa. On the contrary, the more developed countries reported higher disease incidences and mortality rates. However, for Africa, the earlier predictions and modelling into COVID-19 incidence and mortality did not fit into the reality. Therefore, the main objective of this forum is to bring together infectious diseases and public health experts to give an overview of COVID-19 in Africa and share their thoughts and opinions on why Africa behaved the way it did. Furthermore, the experts highlight what needs to be done to support Africa to consolidate the status quo and overcome the negative effects of COVID-19 so as to accelerate attainment of the SDGs.

Identifiants

pubmed: 35501853
doi: 10.1186/s12916-022-02367-4
pii: 10.1186/s12916-022-02367-4
pmc: PMC9059455
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

167

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Medical Research Council
ID : MR/T008822/1
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Health Policy Plan. 2021 Aug 12;36(7):1140-1151
pubmed: 34146394
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Science. 2020 May 8;368(6491):
pubmed: 32234805
Euro Surveill. 2020 May;25(18):
pubmed: 32400361
BMJ Glob Health. 2020 Nov;5(11):
pubmed: 33257418
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Global Health. 2021 Sep 20;17(1):112
pubmed: 34544439
Front Public Health. 2021 Mar 12;9:632043
pubmed: 33777885
Metabol Open. 2021 Dec;12:100124
pubmed: 34541483
Emerg Infect Dis. 2021 Jun;27(6):1598-1606
pubmed: 34013872
Pan Afr Med J. 2021 Jan 05;38:6
pubmed: 33520075
Inquiry. 2021 Jan-Dec;58:469580211060992
pubmed: 34865544
Open Forum Infect Dis. 2021 Jul 09;8(8):ofab367
pubmed: 34381846
Emerg Microbes Infect. 2020 Dec;9(1):727-732
pubmed: 32196410
BMC Public Health. 2021 Sep 1;21(1):1607
pubmed: 34470630
Pan Afr Med J. 2020 Aug 11;35(Suppl 2):143
pubmed: 33193958
Bull World Health Organ. 2007 Jun;85(6):449-57
pubmed: 17639242
Transl Res. 2021 Jun;232:60-74
pubmed: 33582244
World J Biol Chem. 2020 Sep 27;11(2):14-29
pubmed: 33024515
BMC Public Health. 2022 Jan 13;22(1):88
pubmed: 35027023
Front Immunol. 2020 Jun 16;11:1446
pubmed: 32612617
BMJ. 2021 Oct 28;375:n2375
pubmed: 34711605
Arch Med Res. 2020 Aug;51(6):574-576
pubmed: 32446538
Lancet HIV. 2021 Sep;8(9):e524-e526
pubmed: 34363788
Front Immunol. 2020 Nov 05;11:579480
pubmed: 33250893
Nat Med. 2020 Oct;26(10):1616-1622
pubmed: 32770169
Cell Rep Med. 2021 Jul 20;2(7):100354
pubmed: 34250512
Am J Transl Res. 2020 Oct 15;12(10):6537-6548
pubmed: 33194050
BMC Med. 2021 Nov 19;19(1):303
pubmed: 34794434
Public Health Pract (Oxf). 2020 Nov;1:100038
pubmed: 34173573
Epidemiol Infect. 2019 Nov 11;147:e299
pubmed: 31709961
Rev Med Virol. 2022 Mar;32(2):e2271
pubmed: 34228851
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33028699
Glob Health Sci Pract. 2021 Sep 30;9(3):433-443
pubmed: 34593571
PLoS Curr. 2017 Sep 5;9:
pubmed: 29034123
Eval Program Plann. 2016 Apr;55:144-54
pubmed: 26874233
Front Psychol. 2022 Feb 04;13:811863
pubmed: 35185731
Front Immunol. 2018 Oct 09;9:2240
pubmed: 30356736
Science. 2021 Jan 1;371(6524):79-82
pubmed: 33177105
Am J Trop Med Hyg. 2017 Jun;96(6):1296-1301
pubmed: 28719276
Nature. 2022 Feb;602(7896):184
pubmed: 35140392
Cell Rep. 2021 Jun 29;35(13):109320
pubmed: 34146478
Science. 2021 Dec 24;374(6575):1621-1626
pubmed: 34751595
Stem Cell Res. 2020 Dec 15;50:102125
pubmed: 33341604
Pan Afr Med J. 2020 Apr 21;35(Suppl 2):8
pubmed: 32528619
Trop Med Infect Dis. 2019 Sep 29;4(4):
pubmed: 31569517
BMC Med Res Methodol. 2021 Feb 10;21(1):28
pubmed: 33568054
BMJ Sex Reprod Health. 2021 Oct;47(4):252-260
pubmed: 33579717
Malar J. 2017 Apr 11;16(1):145
pubmed: 28399920
BMJ Glob Health. 2021 Mar;6(3):
pubmed: 33789869
Biochem Biophys Res Commun. 2021 Mar 5;543:45-49
pubmed: 33515911
Clin Infect Dis. 2022 Jan 29;74(2):288-293
pubmed: 33893491
J Infect Dis. 2019 Feb 23;219(6):936-944
pubmed: 30307567
Can Commun Dis Rep. 2017 Oct 05;43(10):206-211
pubmed: 29770047
Science. 2020 Oct 2;370(6512):89-94
pubmed: 32753554
Nat Hum Behav. 2021 Jul;5(7):947-953
pubmed: 33972767
Curr Opin Immunol. 2021 Aug;71:111-116
pubmed: 34330017
Int J Infect Dis. 2020 Oct;99:482-484
pubmed: 32861825
Lancet Planet Health. 2020 Dec;4(12):e577-e587
pubmed: 33278375
Cell Host Microbe. 2020 Apr 8;27(4):671-680.e2
pubmed: 32183941
Am J Trop Med Hyg. 2021 Feb 11;104(4):1179-1187
pubmed: 33571138
Nat Rev Immunol. 2021 Dec;21(12):762-768
pubmed: 34667307
JAMA. 2020 May 19;323(19):1891-1892
pubmed: 32293639
Infect Dis Poverty. 2020 Apr 21;9(1):40
pubmed: 32312320
Int J Infect Dis. 2021 Jan;102:577-583
pubmed: 33176202
S Afr Med J. 2020 Dec 15;0(0):13185
pubmed: 33334393
Front Public Health. 2020 May 29;8:241
pubmed: 32574307
Front Microbiol. 2020 Jun 18;11:1476
pubmed: 32625198
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Semin Immunopathol. 2017 Nov;39(6):643-652
pubmed: 28685270
Resour Conserv Recycl. 2021 Jan;164:105169
pubmed: 32982059
EBioMedicine. 2021 Aug;70:103495
pubmed: 34304047
BMC Health Serv Res. 2021 Jul 26;21(1):740
pubmed: 34311716
Nat Commun. 2021 Oct 6;12(1):5851
pubmed: 34615863
Lancet Microbe. 2021 Aug;2(8):e349
pubmed: 34124702
Confl Health. 2020 Jul 31;14:54
pubmed: 32754225
Glob Health Res Policy. 2020 Jul 1;5:33
pubmed: 32617414
Lancet. 2020 Mar 14;395(10227):871-877
pubmed: 32087820
PLoS One. 2021 Aug 27;16(8):e0256330
pubmed: 34449773
Front Immunol. 2020 Jun 18;11:1202
pubmed: 32625209
Int Perspect Sex Reprod Health. 2020 Apr 16;46:73-76
pubmed: 32343244
Health Aff (Millwood). 2020 Sep;39(9):1624-1632
pubmed: 32663045
AAS Open Res. 2021 Jan 13;4:2
pubmed: 34729457
Malar J. 2022 Feb 14;21(1):48
pubmed: 35164781
BMJ Glob Health. 2020 May;5(5):
pubmed: 32451367
Health Hum Rights. 2021 Jun;23(1):273-288
pubmed: 34194219
PLoS One. 2022 Feb 7;17(2):e0261904
pubmed: 35130289
Front Immunol. 2018 Oct 16;9:2135
pubmed: 30386324
Int J Health Policy Manag. 2022 Feb 01;11(2):100-102
pubmed: 33949818
Int J Gen Med. 2021 May 07;14:1757-1762
pubmed: 33994804

Auteurs

Godfrey Bwire (G)

Department of Integrated Epidemiology Surveillance and Public Health Emergencies, Ministry of Health, P.O Box 7272, Kampala, Uganda. gbwire1@yahoo.com.
School of Public Health, Makerere University, P.O. Box 7072, Kampala, Uganda. gbwire1@yahoo.com.

Alex Riolexus Ario (AR)

Uganda National Institute of Public Health, Kampala, Uganda.

Patricia Eyu (P)

Uganda National Institute of Public Health, Kampala, Uganda.

Felix Ocom (F)

Uganda National Institute of Public Health, Kampala, Uganda.

Joseph F Wamala (JF)

World Health Organization (WHO), Juba, South Sudan.

Kwadwo A Kusi (KA)

Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.

Latif Ndeketa (L)

Malawi-Liverpool-Wellcome Programme (MLW), Blantyre, Malawi.

Kondwani C Jambo (KC)

Malawi-Liverpool-Wellcome Programme (MLW), Blantyre, Malawi.
Liverpool School of Tropical Medicine, Liverpool, UK.

Rhoda K Wanyenze (RK)

School of Public Health, Makerere University, P.O. Box 7072, Kampala, Uganda.

Ambrose O Talisuna (AO)

Epidemic Preparedness and Response Cluster, World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH